Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)V600E Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis

Hiroshi Yokomichi; Takashi Inozume; Makoto Wada; Jun Asai; Hiroshi Igaki; Kenjiro Namikawa; Ayato Hayashi; Satoshi Fukushima; Taku Fujimura; Hiroshi Koga; Yasuhiro Nakamura; Mie Mochizuki; Zentaro Yamagata

doi:10.31662/jmaj.2020-0016

Concordance and Discordance Rates of V-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)^V600E Status in Metastatic against Primary Lesion of Melanoma: A Meta-analysis

JMA J. 2020 Jul 15;3(3):274-279. doi: 10.31662/jmaj.2020-0016. Epub 2020 Jul 7.

Authors

Affiliations

¹ Department of Health Sciences, University of Yamanashi, Chuo, Japan.
² Department of Dermatology, University of Yamanashi, Chuo, Japan.
³ Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
⁴ Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
⁵ Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
⁶ Department of Plastic and Reconstructive Surgery, Juntendo University Urayasu Hospital, Urayasu, Japan.
⁷ Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
⁸ Department of Dermatology, Tohoku University, Sendai, Japan.
⁹ Department of Dermatology, Shinshu University School of Medicine, Matsumoto, Japan.
¹⁰ Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Hidaka, Japan.
¹¹ Department of Pediatrics, University of Yamanashi, Chuo, Japan.

No abstract available

Keywords: BRAF mutation; BRAFV600E; disagreement; melanoma; metastasis; mitogen-activated protein kinase kinase inhibitor; primary tumor; serine-threonine protein kinase BRAF inhibitor.